BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9

• Press Releases

  Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21

  July 8, 2025

   · 

  5 min read
• Press Releases

  Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia

  July 8, 2025

   · 

  5 min read
• Press Releases

  OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025

  July 8, 2025

   · 

  3 min read
• Press Releases

  Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

  July 8, 2025

   · 

  9 min read
• Press Releases

  Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

  July 8, 2025

   · 

  10 min read
• Press Releases

  CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

  July 8, 2025

   · 

  7 min read
• Press Releases

  Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome

  July 8, 2025

   · 

  6 min read
• Press Releases

  Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

  July 8, 2025

   · 

  5 min read
• Press Releases

  BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development

  July 8, 2025

   · 

  5 min read
• Press Releases

  Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

  July 8, 2025

   · 

  2 min read